Menu Menu

RPRX    Royalty Pharma Plc    1802768    
Income Statement
Revenue 564,690,000
Net Income 543,987,000
Profit Margin 96.33%

Balance Sheet
Current Assets 1,794,195,000
Assets 18,042,242,000
Current Liabilities 1,167,758,000
Liabilities 7,783,775,000
Equity 10,258,467,000
Shares Out 448,132,000

Cash Flow Statement
Operating Cash Flow 2,026,461,000
Investing Cash Flow -2,172,527,000

Market Analysis
Market Cap 16,868,639,706
Price 30.75
BVPS 22.89
PB 1.34
EPS 1.50
PE 18.77
PS 7.47
FCF -146,066,000
Dividends
Dividend Amount 0.21   
Dividend Yield 3.15%
Jan Feb Mar
Ex: 2/15 Pay: 3/15
Apr May Jun
Ex: 5/16 Pay: 6/14
Jul Aug Sep
Ex: 8/16 Pay: 9/13
Oct Nov Dec
Ex: 11/15 Pay: 12/10

Earnings
Jan Feb Mar
2/15
Apr May Jun
5/09
Jul Aug Sep
8/08
Oct Nov Dec
11/6 1.22

Find a discrepancy? The most accurate way to find company fundamental data is to view RPRX documents filed with the SEC.


RPRX Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: